CAS: 839713-36-9 - N-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-N′-(2,4-difluorophenyl)urea
Formula:C18H15BrF2N4O2
InChI:InChI=1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26)
InChI key:InChIKey=COSPVUFTLGQDQL-UHFFFAOYSA-N
SMILES:O=C(NC=1C=CC(OC)=C(C1)C2=C(Br)C=NN2C)NC3=CC=C(F)C=C3F
- Synonyms:
- 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
- APD 125
- N-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-N′-(2,4-difluorophenyl)urea
- 1-(2,4-Difluorophenyl)-3-[4-methoxy-3-(4-bromo-1-methyl-1H-pyrazol-5-yl)phenyl]urea
- Urea, N-[3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-N′-(2,4-difluorophenyl)-
1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
CAS:839713-36-9
Formula:
C18H15BrF2N4O2
Purity:
97%
Color and Shape:
Solid
Molecular weight:
437.2381
Ref: IN-DA00G3SM
1g | To inquire | ||
50mg | 158.00 € | ||
100mg | 292.00 € | ||
250mg | 535.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Nelotanserin
CAS:839713-36-9
Nelotanserin (APD125): strong 5-HT2A inverse agonist (IC50: 1.7 nM), moderate 5-HT2C (79 nM), weak 5-HT2B …
Formula:
C18H15BrF2N4O2
Purity:
98.01% - 98.42%
Color and Shape:
Solid
Molecular weight:
437.24
Ref: TM-T7350
1mg | 40.00 € | ||
2mg | 52.00 € | ||
5mg | 86.00 € | ||
10mg | 118.00 € | ||
25mg | 185.00 € | ||
50mg | 343.00 € | ||
100mg | 510.00 € | ||
500mg | 1,109.00 € | ||
1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Nelotanserin
CAS:839713-36-9
1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea is the active ingredient in a drug that is used to treat chronic schizophrenia. …
Formula:
C18H15BrF2N4O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
437.24 g/mol
Ref: 3D-FB101032
5mg | 156.00 € | ||
10mg | 184.00 € | ||
25mg | 325.00 € | ||
50mg | 469.00 € | ||
100mg | 669.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024